GALMED PHARMACEUTICALS LTD. (GLMD) Shareholders’ equity 2016–2020
GALMED PHARMACEUTICALS LTD. (GLMD) shareholders’ equity at each fiscal year-end, per SEC filings.
$44.2MFY2020 · since FY2016: $11.1M → $44.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2020 | $44.2M | -36.8% |
| FY2019 | $69.9M | -20.5% |
| FY2018 | $87.9M | +456.5% |
| FY2017 | $15.8M | +42.6% |
| FY2016 | $11.1M | — |
Source: SEC XBRL filings · For reference only · Not investment advice